BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19184429)

  • 1. Factors associated with symptom response to pyloric injection of botulinum toxin in a large series of gastroparesis patients.
    Coleski R; Anderson MA; Hasler WL
    Dig Dis Sci; 2009 Dec; 54(12):2634-42. PubMed ID: 19184429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle.
    Miller LS; Szych GA; Kantor SB; Bromer MQ; Knight LC; Maurer AH; Fisher RS; Parkman HP
    Am J Gastroenterol; 2002 Jul; 97(7):1653-60. PubMed ID: 12135014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis.
    Ezzeddine D; Jit R; Katz N; Gopalswamy N; Bhutani MS
    Gastrointest Endosc; 2002 Jun; 55(7):920-3. PubMed ID: 12024156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review on intrapyloric botulinum toxin injection for gastroparesis.
    Bai Y; Xu MJ; Yang X; Xu C; Gao J; Zou DW; Li ZS
    Digestion; 2010; 81(1):27-34. PubMed ID: 20029206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus.
    Lacy BE; Crowell MD; Schettler-Duncan A; Mathis C; Pasricha PJ
    Diabetes Care; 2004 Oct; 27(10):2341-7. PubMed ID: 15451898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis.
    Bromer MQ; Friedenberg F; Miller LS; Fisher RS; Swartz K; Parkman HP
    Gastrointest Endosc; 2005 Jun; 61(7):833-9. PubMed ID: 15933684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyloric distensibility measurement predicts symptomatic response to intrapyloric botulinum toxin injection.
    Desprez C; Melchior C; Wuestenberghs F; Zalar A; Jacques J; Leroi AM; Gourcerol G
    Gastrointest Endosc; 2019 Nov; 90(5):754-760.e1. PubMed ID: 31028783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic pyloric injection of botulinum toxin-A for the treatment of postvagotomy gastroparesis.
    Reddymasu SC; Singh S; Sankula R; Lavenbarg TA; Olyaee M; McCallum RW
    Am J Med Sci; 2009 Mar; 337(3):161-4. PubMed ID: 19174691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin A for the treatment of delayed gastric emptying.
    Friedenberg FK; Palit A; Parkman HP; Hanlon A; Nelson DB
    Am J Gastroenterol; 2008 Feb; 103(2):416-23. PubMed ID: 18070232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative Pyloric Interventions during Oesophagectomy: a Multicentre Study.
    Marchese S; Qureshi YA; Hafiz SP; Dawas K; Turner P; Mughal MM; Mohammadi B
    J Gastrointest Surg; 2018 Aug; 22(8):1319-1324. PubMed ID: 29667092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic intrapyloric injection of botulinum toxin A in the treatment of children with gastroparesis: a retrospective, open-label study.
    Rodriguez L; Rosen R; Manfredi M; Nurko S
    Gastrointest Endosc; 2012 Feb; 75(2):302-9. PubMed ID: 22248598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin for the treatment of gastroparesis: a preliminary report.
    Lacy BE; Zayat EN; Crowell MD; Schuster MM
    Am J Gastroenterol; 2002 Jun; 97(6):1548-52. PubMed ID: 12094882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyloric sphincter characteristics using EndoFLIP
    Saadi M; Yu D; Malik Z; Parkman HP; Schey R
    Rev Gastroenterol Mex (Engl Ed); 2018; 83(4):375-384. PubMed ID: 29709494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum Toxin A Improves Symptoms of Gastroparesis.
    Reichenbach ZW; Stanek S; Patel S; Ward SJ; Malik Z; Parkman HP; Schey R
    Dig Dis Sci; 2020 May; 65(5):1396-1404. PubMed ID: 31617132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyloric injection of botulinum toxin for the treatment of refractory GERD accompanied with gastroparesis: a preliminary report.
    Mirbagheri SA; Sadeghi A; Amouie M; Mansouri S; Forootan M; Rashidi A; Abouzari M
    Dig Dis Sci; 2008 Oct; 53(10):2621-6. PubMed ID: 18256933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin for prevention of delayed gastric emptying after esophagectomy.
    Bagheri R; Fattahi SH; Haghi SZ; Aryana K; Aryanniya A; Akhlaghi S; Riyabi FN; Sheibani S
    Asian Cardiovasc Thorac Ann; 2013 Dec; 21(6):689-92. PubMed ID: 24569327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of botulinum toxin injection for the treatment of delayed gastric emptying following esophagectomy.
    Kent MS; Pennathur A; Fabian T; McKelvey A; Schuchert MJ; Luketich JD; Landreneau RJ
    Surg Endosc; 2007 May; 21(5):754-7. PubMed ID: 17458616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients.
    Arts J; van Gool S; Caenepeel P; Verbeke K; Janssens J; Tack J
    Aliment Pharmacol Ther; 2006 Aug; 24(4):661-7. PubMed ID: 16907899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum Toxin Injection for Treatment of Gastroparesis.
    Pasricha TS; Pasricha PJ
    Gastrointest Endosc Clin N Am; 2019 Jan; 29(1):97-106. PubMed ID: 30396531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type A for treatment of refractory gastroparesis.
    DeSantis ER; Huang S
    Am J Health Syst Pharm; 2007 Nov; 64(21):2237-40. PubMed ID: 17959574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.